Sipos, Á.; Szennyes, E.; Hajnal, N.É.; Kun, S.; Szabó, K.E.; Uray, K.; Somsák, L.; Docsa, T.; Bokor, É.
Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors. Pharmaceuticals 2021, 14, 364.
https://doi.org/10.3390/ph14040364
AMA Style
Sipos Á, Szennyes E, Hajnal NÉ, Kun S, Szabó KE, Uray K, Somsák L, Docsa T, Bokor É.
Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors. Pharmaceuticals. 2021; 14(4):364.
https://doi.org/10.3390/ph14040364
Chicago/Turabian Style
Sipos, Ádám, Eszter Szennyes, Nikolett Éva Hajnal, Sándor Kun, Katalin E. Szabó, Karen Uray, László Somsák, Tibor Docsa, and Éva Bokor.
2021. "Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors" Pharmaceuticals 14, no. 4: 364.
https://doi.org/10.3390/ph14040364
APA Style
Sipos, Á., Szennyes, E., Hajnal, N. É., Kun, S., Szabó, K. E., Uray, K., Somsák, L., Docsa, T., & Bokor, É.
(2021). Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors. Pharmaceuticals, 14(4), 364.
https://doi.org/10.3390/ph14040364